NCT06231186View on ClinicalTrials.gov

a Feasibility Study of iHD-SRT for BM

NARecruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

March 15, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Brain Metastases, AdultStereotactic Radiotherapy
Interventions
RADIATION

iHD-SRT

received isotoxic individualized fSRT, with BED 10\>50Gy and \<100Gy, and strict OAR limits

Trial Locations (1)

200000

RECRUITING

Ruijin Hospital, Shanghai

All Listed Sponsors
lead

Ruijin Hospital

OTHER